Genomes for kids: the scope of pathogenic mutations in pediatric cancer revealed by comprehensive DNA and RNA sequencing

S Newman, J Nakitandwe, CA Kesserwan, EM Azzato… - Cancer discovery, 2021 - AACR
Genomic studies of pediatric cancer have primarily focused on specific tumor types or high-
risk disease. Here, we used a three-platform sequencing approach, including whole …

Aldehyde-Associated Mutagenesis─ Current State of Knowledge

S Vijayraghavan, N Saini - Chemical Research in Toxicology, 2023 - ACS Publications
Aldehydes are widespread in the environment, with multiple sources such as food and
beverages, industrial effluents, cigarette smoke, and additives. The toxic effects of exposure …

Comprehensive genomic profiling of neuroendocrine carcinomas of the gastrointestinal system

S Yachida, Y Totoki, M Noë, Y Nakatani, M Horie… - Cancer discovery, 2022 - AACR
The neuroendocrine carcinoma of the gastrointestinal system (GIS-NEC) is a rare but highly
malignant neoplasm. We analyzed 115 cases using whole-genome/exome sequencing …

Genomic landscape and clinical utility in Korean advanced pan-cancer patients from prospective clinical sequencing: K-MASTER program

KH Park, JY Choi, AR Lim, JW Kim, YJ Choi, S Lee… - Cancer Discovery, 2022 - AACR
The fundamental principle of precision oncology is centralized on the identification of
therapeutically exploitable targets that provides individual patients with cancer an …

Early tumor–immune microenvironmental remodeling and response to first-line fluoropyrimidine and platinum chemotherapy in advanced gastric cancer

R Kim, M An, H Lee, A Mehta, YJ Heo, KM Kim, SY Lee… - Cancer discovery, 2022 - AACR
Chemotherapy is ubiquitous in first-line treatment of advanced gastric cancer, yet responses
are heterogeneous, and little is known about mediators of chemotherapy response. To move …

Sex-Biased ZRSR2 Mutations in Myeloid Malignancies Impair Plasmacytoid Dendritic Cell Activation and Apoptosis

K Togami, SS Chung, V Madan, CAG Booth… - Cancer discovery, 2022 - AACR
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive leukemia of
plasmacytoid dendritic cells (pDC). BPDCN occurs at least three times more frequently in …

Loss of TGFβ signaling increases alternative end-joining DNA repair that sensitizes to genotoxic therapies across cancer types

Q Liu, L Palomero, J Moore, I Guix, R Espín… - Science translational …, 2021 - science.org
Among the pleotropic roles of transforming growth factor–β (TGFβ) signaling in cancer, its
impact on genomic stability is least understood. Inhibition of TGFβ signaling increases use of …

[HTML][HTML] Structure-guided inhibition of the cancer DNA-mutating enzyme APOBEC3A

S Harjes, HM Kurup, AE Rieffer, M Bayarjargal… - Nature …, 2023 - nature.com
The normally antiviral enzyme APOBEC3A is an endogenous mutagen in human cancer. Its
single-stranded DNA C-to-U editing activity results in multiple mutagenic outcomes including …

DNA damage and oxidative stress of tobacco smoke condensate in human bladder epithelial cells

M Bellamri, SJ Walmsley, C Brown… - Chemical research in …, 2022 - ACS Publications
Smoking is a major risk factor for bladder cancer (BC), with up to 50% of BC cases being
attributed to smoking. There are 70 known carcinogens in tobacco smoke; however, the …

[HTML][HTML] Impact of cancer evolution on immune surveillance and checkpoint inhibitor response

Y Wu, D Biswas, C Swanton - Seminars in cancer biology, 2022 - Elsevier
Intratumour heterogeneity (ITH) is pervasive across all cancers studied and may provide the
evolving tumour multiple routes to escape immune surveillance. Immune checkpoint …